{"id":"covid-19-standard-treatment","safety":{"commonSideEffects":[{"rate":"null","effect":"Pain, redness, or swelling at the injection site"}]},"_chembl":{"chemblId":"CHEMBL5314794","moleculeType":"Protein"},"_dailymed":null,"mechanism":{"_ai_source":"groq-llama-8b","explanation":"The exact mechanism of action is not fully understood, but it is believed to work by binding to the spike protein of the SARS-CoV-2 virus, preventing it from entering host cells.","oneSentence":"This drug targets the SARS-CoV-2 virus to prevent COVID-19 infection.","_ai_confidence":"high"},"_scrapedAt":"2026-03-28T03:29:11.651Z","_scrapedBy":"cloudflare-swarm","_wikipedia":null,"indications":{"approved":[{"name":"Prevention of COVID-19 disease"}]},"trialDetails":[{"nctId":"NCT04305457","phase":"PHASE2","title":"Nitric Oxide Gas Inhalation Therapy for Mild/Moderate COVID-19","status":"TERMINATED","sponsor":"Massachusetts General Hospital","startDate":"2020-03-21","conditions":"Coronavirus Infections, Pneumonia, Viral, Acute Respiratory Distress Syndrome","enrollment":62},{"nctId":"NCT03684980","phase":"EARLY_PHASE1","title":"LTA Pilot Study of Glucarpidase in Patients With Central Nervous System Lymphoma","status":"ACTIVE_NOT_RECRUITING","sponsor":"Memorial Sloan Kettering Cancer Center","startDate":"2018-11-14","conditions":"Central Nervous System Lymphoma","enrollment":58},{"nctId":"NCT04488081","phase":"PHASE2","title":"I-SPY COVID-19 TRIAL: An Adaptive Platform Trial for Critically Ill Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"QuantumLeap Healthcare Collaborative","startDate":"2020-07-31","conditions":"COVID-19","enrollment":1500},{"nctId":"NCT04055948","phase":"NA","title":"Building Family Caregiver Skills Using a Simulation-Based Intervention for Care of Cancer Patients","status":"COMPLETED","sponsor":"Case Comprehensive Cancer Center","startDate":"2019-12-17","conditions":"Cancer","enrollment":484},{"nctId":"NCT07450209","phase":"PHASE2","title":"COVID-19 Rapid Test-to-Treat With African American Churches (Faithful Response II)","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Missouri, Kansas City","startDate":"2024-05-15","conditions":"COVID-19 Testing Behaviors","enrollment":900},{"nctId":"NCT05254990","phase":"PHASE3","title":"Reparixin add-on Therapy to Standard Care to Limit Progression in Pts With COVID19 & Other Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Dompé Farmaceutici S.p.A","startDate":"2022-04-27","conditions":"Infectious Pneumonia, Severe COVID-19","enrollment":414},{"nctId":"NCT06343545","phase":"NA","title":"The Tele-Rehab MV Cluster Stepped-Wedge Randomized Clinical Trial","status":"COMPLETED","sponsor":"Hospital Israelita Albert Einstein","startDate":"2024-06-10","conditions":"Acute Respiratory Failure","enrollment":1916},{"nctId":"NCT06452095","phase":"NA","title":"Recovering From COVID-19 Lingering Symptoms Adaptive Integrative Medicine Trial - Effect of Hyperbaric Oxygen Therapy for the Treatment of Post COVID Condition","status":"RECRUITING","sponsor":"University Health Network, Toronto","startDate":"2026-01-01","conditions":"Long COVID, Post Acute Sequelae of COVID-19, Post-COVID-19 Condition","enrollment":120},{"nctId":"NCT07209267","phase":"PHASE2","title":"Baricitinib Curative Repression of HIV-1","status":"NOT_YET_RECRUITING","sponsor":"Emory University","startDate":"2026-03","conditions":"HIV Infection, HIV","enrollment":20},{"nctId":"NCT05419128","phase":"NA","title":"Family-focused vs. Drinker-focused Smartphone Interventions to Reduce Drinking-related Consequences of COVID-19","status":"COMPLETED","sponsor":"University of Wisconsin, Madison","startDate":"2022-04-06","conditions":"Alcohol Use Disorder, Family Members, Behavior, Addictive","enrollment":398},{"nctId":"NCT07406217","phase":"PHASE2","title":"OPtimisation of Antiviral Therapy in Immunocompromised COVID-19 Patients","status":"RECRUITING","sponsor":"Calmy Alexandra","startDate":"2023-04-27","conditions":"COVID-19, Immunodeficiency","enrollment":256},{"nctId":"NCT03656926","phase":"PHASE3","title":"Efficacy + Safety of Liposome Cyclosporine A to Treat Bronchiolitis Obliterans Post Double Lung Transplant (BOSTON-2)","status":"COMPLETED","sponsor":"Zambon SpA","startDate":"2019-03-26","conditions":"Bronchiolitis Obliterans, Chronic Rejection of Lung Transplant, Lung Transplant Rejection","enrollment":169},{"nctId":"NCT04415060","phase":"PHASE3","title":"SedAting With Volatile Anesthetics Critically Ill COVID-19 Patients in ICU: Effects On Ventilatory Parameters And Survival","status":"ACTIVE_NOT_RECRUITING","sponsor":"Sunnybrook Health Sciences Centre","startDate":"2020-06-15","conditions":"Covid19, Hypoxic Respiratory Failure","enrollment":800},{"nctId":"NCT07374991","phase":"NA","title":"Clinical and Molecular Effects of N-Acetylcysteine Treatment in COVID-19-Related Acute Respiratory Distress Syndrome","status":"COMPLETED","sponsor":"University of Gaziantep","startDate":"2020-11-01","conditions":"COVID-19-Associated Acute Respiratory Distress Syndrome (ARDS)","enrollment":59},{"nctId":"NCT05405712","phase":"NA","title":"Mobile Peer Support for OUD Recovery","status":"ACTIVE_NOT_RECRUITING","sponsor":"Brown University","startDate":"2022-05-12","conditions":"Opioid Use Disorder","enrollment":1300},{"nctId":"NCT04591210","phase":"PHASE3","title":"The COVID-RASi Trial (COVID-19)","status":"COMPLETED","sponsor":"Ottawa Heart Institute Research Corporation","startDate":"2021-01-27","conditions":"COVID-19, Cardiovascular Diseases","enrollment":372},{"nctId":"NCT04910269","phase":"PHASE3","title":"Outpatient Treatment With Anti-Coronavirus Immunoglobulin","status":"RECRUITING","sponsor":"University of Minnesota","startDate":"2021-08-06","conditions":"COVID, SARS-CoV2 Infection, Covid19","enrollment":820},{"nctId":"NCT05090865","phase":"NA","title":"Dietary Potassium Liberalization in Pre-Dialysis Patients","status":"RECRUITING","sponsor":"University of Manitoba","startDate":"2024-01-15","conditions":"Chronic Kidney Disease, Hyperkalemia","enrollment":30},{"nctId":"NCT04746183","phase":"PHASE1, PHASE2","title":"AGILE (Early Phase Platform Trial for COVID-19)","status":"RECRUITING","sponsor":"University of Liverpool","startDate":"2020-07-03","conditions":"Covid19","enrollment":600},{"nctId":"NCT04379518","phase":"PHASE1, PHASE2","title":"Rintatolimod and IFN Alpha-2b for the Treatment of COVID-19 in Cancer Patients","status":"TERMINATED","sponsor":"Roswell Park Cancer Institute","startDate":"2020-11-17","conditions":"Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm, Symptomatic COVID-19 Infection Laboratory-Confirmed","enrollment":4},{"nctId":"NCT06202521","phase":"PHASE2","title":"CX-4945 in Viral Community Acquired Pneumonia","status":"TERMINATED","sponsor":"Senhwa Biosciences, Inc.","startDate":"2024-03-20","conditions":"Community-acquired Pneumonia, SARS-CoV-2 -Associated Pneumonia, Influenza With Pneumonia","enrollment":45},{"nctId":"NCT05077254","phase":"PHASE2","title":"COVID Protection After Transplant-Immunosuppression Reduction","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-12-06","conditions":"Kidney Transplant Recipients, Liver Transplant Recipients","enrollment":48},{"nctId":"NCT06189066","phase":"NA","title":"Long COVID Ultrasound Trial","status":"COMPLETED","sponsor":"SecondWave Systems Inc.","startDate":"2024-01-03","conditions":"Long Covid","enrollment":15},{"nctId":"NCT04452097","phase":"PHASE1, PHASE2","title":"Use of hUC-MSC Product (BX-U001) for the Treatment of COVID-19 With ARDS","status":"WITHDRAWN","sponsor":"Baylx Inc.","startDate":"2026-06-01","conditions":"COVID-19, ARDS, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT06821087","phase":"PHASE2","title":"Evaluating the Neuromodulatory Effect of Ketamine in Long COVID-19","status":"ENROLLING_BY_INVITATION","sponsor":"University of Texas at Austin","startDate":"2025-04-28","conditions":"Long COVID","enrollment":20},{"nctId":"NCT05228275","phase":"","title":"Evaluation of Immunologic Response Following COVID-19 Vaccination in Children, Adolescents, and Young Adults With Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Children's Oncology Group","startDate":"2022-04-08","conditions":"COVID-19 Infection, Hematopoietic and Lymphatic System Neoplasm, Malignant Solid Neoplasm","enrollment":549},{"nctId":"NCT07280572","phase":"PHASE3","title":"RECLAIM Adaptive Platform Trial for PCC Treatments","status":"ENROLLING_BY_INVITATION","sponsor":"Janneke van de Wijgert","startDate":"2025-02-17","conditions":"Post COVID Condition","enrollment":1250},{"nctId":"NCT04780659","phase":"PHASE4","title":"COVID-19 Vaccination of Immunodeficient Persons (COVAXID)","status":"COMPLETED","sponsor":"Karolinska University Hospital","startDate":"2021-02-23","conditions":"Covid19","enrollment":539},{"nctId":"NCT06992401","phase":"","title":"Observational Study of Intranasal IVIG in Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Patients Undergoing Medical Tourism","status":"NOT_YET_RECRUITING","sponsor":"Tamara C Tamas","startDate":"2026-08-01","conditions":"Post-Acute Sequelae of SARS-CoV-2 Infection, Long COVID, Long COVID Fatigue","enrollment":50},{"nctId":"NCT07110714","phase":"NA","title":"Effects of Kneipp Hydrotherapy in Post-COVID-19 Patients","status":"RECRUITING","sponsor":"Eggensberger OHG","startDate":"2025-12-01","conditions":"Post COVID-19 Condition, Post COVID-19 Condition (PCC), Post COVID-19","enrollment":30},{"nctId":"NCT04393038","phase":"PHASE2, PHASE3","title":"ABX464 in Treating Inflammation and Preventing Acute Respiratory Failure in Patients With COVID-19","status":"TERMINATED","sponsor":"Abivax S.A.","startDate":"2020-07-01","conditions":"COVID-19","enrollment":509},{"nctId":"NCT05852873","phase":"PHASE3","title":"PAxlovid loNg cOvid-19 pRevention triAl With recruitMent In the Community in Norway","status":"ACTIVE_NOT_RECRUITING","sponsor":"Haukeland University Hospital","startDate":"2023-05-12","conditions":"Post COVID-19 Condition, Unspecified, SARS-CoV2 Infection, COVID-19","enrollment":2000},{"nctId":"NCT04469491","phase":"PHASE2","title":"Treatment of COVID-19 by Nebulization of Inteferon Beta 1b Efficiency and Safety Study","status":"ACTIVE_NOT_RECRUITING","sponsor":"Centre Hospitalier Universitaire, Amiens","startDate":"2020-09-20","conditions":"COVID-19, INTERFERON, NEBULIZATION","enrollment":74},{"nctId":"NCT04581954","phase":"PHASE1, PHASE2","title":"Inflammatory Signal Inhibitors for COVID-19 (MATIS)","status":"COMPLETED","sponsor":"Imperial College London","startDate":"2020-10-02","conditions":"Coronavirus, Covid19, Pneumonia","enrollment":185},{"nctId":"NCT03998462","phase":"NA","title":"Mindfulness Based Stress Reduction for Parkinson's Disease: A Longitudinal Study","status":"COMPLETED","sponsor":"VA Office of Research and Development","startDate":"2020-01-01","conditions":"Parkinson's Disease","enrollment":107},{"nctId":"NCT05102656","phase":"NA","title":"Patient Perceptions of the Relational Empathy of Healthcare Practitioners From the Department of Emergency Medicine During the COVID-19 Pandemic","status":"ACTIVE_NOT_RECRUITING","sponsor":"M.D. Anderson Cancer Center","startDate":"2021-06-02","conditions":"COVID-19 Infection, Hematopoietic and Lymphoid Cell Neoplasm, Malignant Solid Neoplasm","enrollment":107},{"nctId":"NCT04545541","phase":"PHASE2, PHASE3","title":"Nebulised Heparin in Patients With Severe COVID-19","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-11-01","conditions":"Covid19, Respiratory Failure","enrollment":57},{"nctId":"NCT06579222","phase":"NA","title":"Comorbidity Management in Rheumatic Disease.","status":"RECRUITING","sponsor":"Western University, Canada","startDate":"2025-05-01","conditions":"Rheumatoid Arthritis, Comorbidities and Coexisting Conditions","enrollment":199},{"nctId":"NCT05113641","phase":"NA","title":"Reducing Dietary Acid With Food Versus Oral Alkali in People With Chronic Kidney Disease (ReDACKD)","status":"RECRUITING","sponsor":"Dylan MacKay","startDate":"2023-08-04","conditions":"Chronic Kidney Diseases, Metabolic Acidosis","enrollment":40},{"nctId":"NCT04803370","phase":"NA","title":"Efficacy of Reinforcing Standard Therapy in COVID-19 Patients With Repeated Transfusion of Convalescent Plasma","status":"COMPLETED","sponsor":"Hospital Son Llatzer","startDate":"2020-07-08","conditions":"Covid19","enrollment":55},{"nctId":"NCT05220163","phase":"NA","title":"Evaluating the Impact of Computer-assisted X-ray Diagnosis and Other Triage Tools to Optimise Xpert Orientated Community-based Active Case Finding for TB and COVID-19","status":"ACTIVE_NOT_RECRUITING","sponsor":"University of Cape Town","startDate":"2022-02-23","conditions":"Tuberculosis, COVID-19, HIV Infections","enrollment":26200},{"nctId":"NCT05552625","phase":"PHASE2, PHASE3","title":"The Efficacy and Safety of TADIOS as an Adjuvant Therapy in Patients Diagnosed With Mild to Moderate COVID-19","status":"WITHDRAWN","sponsor":"Helixmith Co., Ltd.","startDate":"2021-05-06","conditions":"COVID-19","enrollment":""},{"nctId":"NCT04553705","phase":"PHASE2, PHASE3","title":"Omega-3, Nigella Sativa, Indian Costus, Quinine, Anise Seed, Deglycyrrhizinated Licorice, Artemisinin, Febrifugine on Immunity of Patients With (COVID-19)","status":"COMPLETED","sponsor":"Beni-Suef University","startDate":"2020-09-20","conditions":"Covid19, Immunodeficiency","enrollment":150},{"nctId":"NCT05228886","phase":"NA","title":"The SINCERE Intervention to Address COVID-19 Health Disparities","status":"RECRUITING","sponsor":"Andrea Wallace","startDate":"2021-09-27","conditions":"COVID-19, Vulnerable Populations, Social Determinants of Health","enrollment":1500},{"nctId":"NCT04345614","phase":"PHASE2","title":"A Study of Auxora in Patients With Severe COVID-19 Pneumonia","status":"COMPLETED","sponsor":"CalciMedica, Inc.","startDate":"2020-04-08","conditions":"Pneumonia","enrollment":314},{"nctId":"NCT05543642","phase":"PHASE4","title":"The COVID-19 VaccinE Response and Co-Administration in Rheumatology Patients (COVER-CoAd)","status":"ACTIVE_NOT_RECRUITING","sponsor":"Oregon Health and Science University","startDate":"2022-10-11","conditions":"Rheumatic Diseases","enrollment":129},{"nctId":"NCT05570630","phase":"NA","title":"VAX-MOM COVID-19: Increasing Maternal COVID-19 Vaccination","status":"COMPLETED","sponsor":"University of Rochester","startDate":"2022-10-21","conditions":"Immunization; Infection, Pregnancy Related, COVID-19","enrollment":6911},{"nctId":"NCT04482621","phase":"PHASE2","title":"Decitabine for Coronavirus (COVID-19) Pneumonia- Acute Respiratory Distress Syndrome (ARDS) Treatment: DART Trial","status":"SUSPENDED","sponsor":"Johns Hopkins University","startDate":"2020-09-14","conditions":"COVID-19","enrollment":33},{"nctId":"NCT07013903","phase":"NA","title":"Effects of Hydrotherapy During Post-COVID-19 Rehabilitation","status":"RECRUITING","sponsor":"Schön Klinik Berchtesgadener Land","startDate":"2025-08-21","conditions":"Post-COVID / Long-COVID, POST-Covid 19, Post COVID Syndrome","enrollment":50},{"nctId":"NCT06821113","phase":"NA","title":"Vale+Tú Salud: Corner-Based Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19","status":"RECRUITING","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2025-07-03","conditions":"COVID-19","enrollment":150},{"nctId":"NCT04716998","phase":"PHASE1, PHASE2","title":"Safety and the Efficacy of MesenCure for the Treatment of Pulmonary Manifestations of COVID-19","status":"COMPLETED","sponsor":"BonusBio Group Ltd","startDate":"2021-01-14","conditions":"Covid19","enrollment":50},{"nctId":"NCT04356833","phase":"PHASE2","title":"Nebulised Rt-PA for ARDS Due to COVID-19","status":"COMPLETED","sponsor":"University College, London","startDate":"2020-04-22","conditions":"COVID","enrollment":35},{"nctId":"NCT04473053","phase":"PHASE1, PHASE2","title":"DEFINE - Evaluating Therapies for COVID-19","status":"COMPLETED","sponsor":"University of Edinburgh","startDate":"2020-07-03","conditions":"COVID-19","enrollment":71},{"nctId":"NCT04467840","phase":"PHASE2, PHASE3","title":"Opaganib, a Sphingosine Kinase-2 (SK2) Inhibitor in COVID-19 Pneumonia","status":"COMPLETED","sponsor":"RedHill Biopharma Limited","startDate":"2020-08-21","conditions":"COVID-19, Lung Infection","enrollment":475},{"nctId":"NCT04969263","phase":"PHASE2","title":"COVID-19 Protection After Transplant Pilot Study","status":"COMPLETED","sponsor":"National Institute of Allergy and Infectious Diseases (NIAID)","startDate":"2021-08-10","conditions":"Kidney Transplant Recipients","enrollment":81},{"nctId":"NCT07090486","phase":"","title":"A Study to Understand How the Use of Paxlovid Affected Healthcare Use in People With Pre-existing Conditions.","status":"COMPLETED","sponsor":"Pfizer","startDate":"2025-04-15","conditions":"COVID-19","enrollment":14000},{"nctId":"NCT04532931","phase":"PHASE2","title":"Four Different Experimental Drug Regimens to Standard of Care for the Treatment of Symptomatic Outpatients With COVID-19","status":"COMPLETED","sponsor":"Shin Poong Pharmaceutical Co. Ltd.","startDate":"2020-09-03","conditions":"COVID-19","enrollment":192},{"nctId":"NCT06873633","phase":"PHASE2","title":"Safety, Pharmacokinetics, and Antiviral Activity of Remdesivir (VEKLURY®) in Hospitalized Children With RSV","status":"RECRUITING","sponsor":"PENTA Foundation","startDate":"2025-07-16","conditions":"Respiratory Syncytial Virus (RSV)","enrollment":120},{"nctId":"NCT07075939","phase":"","title":"Centralization and Oncologic Outcomes in Ovarian Cancer","status":"ACTIVE_NOT_RECRUITING","sponsor":"Azienda USL Reggio Emilia - IRCCS","startDate":"2025-06-27","conditions":"Epithelial Ovarian Cancer, Ovarian Neoplasms, Advanced Ovarian Cancer","enrollment":200},{"nctId":"NCT04912817","phase":"NA","title":"PR-VR At-home Program During and After COVID-19","status":"COMPLETED","sponsor":"The Hospital for Sick Children","startDate":"2022-09-01","conditions":"Pain, Chronic","enrollment":40},{"nctId":"NCT05459532","phase":"PHASE2, PHASE3","title":"A Randomised, Multi-centre, Double-blind, Phase 3 Study to Observe the Effectiveness, Safety and Tolerability of Molnupiravir Compared to Placebo Administered Orally to High-risk Adult Outpatients With Mild COVID-19 Receiving Local Standard of Care in South Africa","status":"COMPLETED","sponsor":"University of Witwatersrand, South Africa","startDate":"2022-08-12","conditions":"COVID-19","enrollment":59},{"nctId":"NCT07029048","phase":"","title":"Oxidative Stress and Cognitive Dysfunction After COVID-19","status":"COMPLETED","sponsor":"Karaganda Medical University","startDate":"2021-03-01","conditions":"COVID 19, Oxydative Stress, Cognitive Impairments","enrollment":45},{"nctId":"NCT04635241","phase":"PHASE2, PHASE3","title":"Inhaled Heparin for Hospitalised COVID-19 Patients","status":"COMPLETED","sponsor":"Australian National University","startDate":"2020-06-01","conditions":"Covid19","enrollment":485},{"nctId":"NCT05252923","phase":"PHASE4","title":"Endothelial Protection in Convalescent COVID-19 Patients","status":"TERMINATED","sponsor":"Pirogov Russian National Research Medical University","startDate":"2022-04-01","conditions":"Endothelial Dysfunction, Inflammation, Thrombosis","enrollment":2},{"nctId":"NCT04324073","phase":"PHASE2, PHASE3","title":"Cohort Multiple Randomized Controlled Trials Open-label of Immune Modulatory Drugs and Other Treatments in COVID-19 Patients - Sarilumab Trial - CORIMUNO-19 - SARI","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-27","conditions":"Corona Virus Infection","enrollment":239},{"nctId":"NCT04331808","phase":"PHASE2","title":"CORIMUNO-19 - Tocilizumab Trial - TOCI (CORIMUNO-TOCI)","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-03-30","conditions":"Corona Virus Infection","enrollment":228},{"nctId":"NCT04341584","phase":"PHASE2","title":"CORIMUNO-ANA: Trial Evaluating Efficacy Of Anakinra In Patients With Covid-19 Infection","status":"COMPLETED","sponsor":"Assistance Publique - Hôpitaux de Paris","startDate":"2020-04-08","conditions":"Corona Virus Infection","enrollment":161},{"nctId":"NCT05022472","phase":"PHASE4","title":"Project 2VIDA! COVID-19 Vaccine Intervention Delivery for Adults in Southern California","status":"COMPLETED","sponsor":"Britt Skaathun","startDate":"2021-07-16","conditions":"Vaccine Refusal, Covid19","enrollment":1051},{"nctId":"NCT04479358","phase":"PHASE2","title":"Low-dose Tocilizumab Versus Standard of Care in Hospitalized Patients With COVID-19","status":"TERMINATED","sponsor":"University of Chicago","startDate":"2020-09-10","conditions":"COVID-19","enrollment":85},{"nctId":"NCT06997666","phase":"NA","title":"Effect of Prone Position on Oxygen, Blood Gas, and Respiratory Parameters in Intensive Care Patients With COVID-19-induced ARDS","status":"COMPLETED","sponsor":"Medet Korkmaz","startDate":"2021-03-01","conditions":"COVID - 19, ARDS (Acute Respiratory Distress Syndrome)","enrollment":90},{"nctId":"NCT05091307","phase":"PHASE3","title":"A Study of Ad26.COV2.S and Influenza Vaccines in Healthy Adults","status":"COMPLETED","sponsor":"Janssen Vaccines & Prevention B.V.","startDate":"2021-11-02","conditions":"COVID-19 Prevention","enrollment":861},{"nctId":"NCT04347226","phase":"PHASE2","title":"Anti-Interleukin-8 (Anti-IL-8) for Patients With COVID-19","status":"TERMINATED","sponsor":"Columbia University","startDate":"2020-04-16","conditions":"Solid Tumor, Sars-CoV2, Hematological Malignancy","enrollment":43},{"nctId":"NCT04969991","phase":"PHASE2","title":"Study of Varespladib in Patients Hospitalized With Severe COVID-19","status":"TERMINATED","sponsor":"Ophirex, Inc.","startDate":"2021-06-30","conditions":"Coronavirus Disease 2019, Disease Caused by Severe Acute Respiratory Syndrome Coronavirus 2","enrollment":18},{"nctId":"NCT04979884","phase":"PHASE3","title":"Safety and Effectiveness of Cyclosporin in the Management of COVID19 ARDS Patients in Alexandria University Hospital","status":"COMPLETED","sponsor":"Alexandria University","startDate":"2022-01-03","conditions":"COVID-19 Acute Respiratory Distress Syndrome, Cytokine Release Syndrome, Pulmonary Fibrosis","enrollment":66},{"nctId":"NCT06964048","phase":"NA","title":"Evaluation of Cold Plasma in Chronic Wound Healing","status":"NOT_YET_RECRUITING","sponsor":"Plasana Medical","startDate":"2025-06","conditions":"Chronic Wounds, Venous Leg Ulcer (VLU), Diabetic Foot Ulcer (DFU)","enrollment":66},{"nctId":"NCT05286242","phase":"","title":"Evaluating the Immune Response to COVID19 Vaccination in Immunodeficient Patients","status":"ACTIVE_NOT_RECRUITING","sponsor":"Yale University","startDate":"2021-02-10","conditions":"Multiple Sclerosis, Autoimmune Blistering Disease, B-Cell Deficiency","enrollment":400},{"nctId":"NCT06146361","phase":"NA","title":"Vale+Tú Salud: Corner-Based Randomized Trial to Test a Latino Day Laborer Program Adapted to Prevent COVID-19","status":"COMPLETED","sponsor":"The University of Texas Health Science Center, Houston","startDate":"2023-11-03","conditions":"COVID-19","enrollment":359},{"nctId":"NCT04685655","phase":"NA","title":"RescuE pLAsma eXchange in Severe COVID-19","status":"TERMINATED","sponsor":"Heidelberg University","startDate":"2020-01-07","conditions":"Therapeutic Plasma Exchange, Covid19","enrollment":67},{"nctId":"NCT04904536","phase":"PHASE3","title":"Statin TReatment for COVID-19 to Optimise NeuroloGical recovERy","status":"ACTIVE_NOT_RECRUITING","sponsor":"The George Institute","startDate":"2022-03-10","conditions":"Neurocognitive Impairment, Mild","enrollment":190},{"nctId":"NCT04566614","phase":"","title":"Preventing Viral Pandemic Associated Risk of Cancer Death Using Less Invasive Diagnostic Tests- Liquid Biopsies","status":"COMPLETED","sponsor":"Royal Marsden NHS Foundation Trust","startDate":"2020-06-18","conditions":"Neoplasm, Colorectal, Neoplasm of Lung, Neoplasm, Bladder","enrollment":128},{"nctId":"NCT04852770","phase":"NA","title":"Efficacy of TBCT, MBHP and PPT for PTSD During the Covid-19 Pandemics","status":"TERMINATED","sponsor":"Fundação Bahiana de Infectologia","startDate":"2020-04-06","conditions":"Posttraumatic Stress Disorder, Covid19","enrollment":135},{"nctId":"NCT05855330","phase":"PHASE2","title":"Arginine Replacement Therapy in COVID-19","status":"RECRUITING","sponsor":"Emory University","startDate":"2024-01-08","conditions":"COVID-19","enrollment":21},{"nctId":"NCT05530317","phase":"NA","title":"CArdiac REhabilitation for Building Exertional heArt Rate for Chronotropic Incompetence in Long COVID-19","status":"RECRUITING","sponsor":"University of California, San Francisco","startDate":"2022-12-21","conditions":"Long COVID, COVID-19","enrollment":20},{"nctId":"NCT04937543","phase":"PHASE2","title":"Efficacy of Inhaled Therapies in the Treatment of Acute Symptoms Associated With COVID-19","status":"COMPLETED","sponsor":"UPECLIN HC FM Botucatu Unesp","startDate":"2021-06-28","conditions":"Covid19","enrollment":50},{"nctId":"NCT06780566","phase":"NA","title":"Routine Application of Point-of-care PCR Test to Identify and Direct Therapy for Acute Respiratory Infection in the Emergency Department Trial","status":"NOT_YET_RECRUITING","sponsor":"The University of Hong Kong","startDate":"2025-04-30","conditions":"Influenza, COVID-19, Acute Respiratory Infections (ARIs)","enrollment":1050},{"nctId":"NCT04913129","phase":"NA","title":"The Burden of COVID-19 Survivorship","status":"COMPLETED","sponsor":"Mayo Clinic","startDate":"2021-11-04","conditions":"Covid19","enrollment":27},{"nctId":"NCT05060991","phase":"PHASE4","title":"Impact of Immunosuppression Adjustment on COVID-19 Vaccination Response in Kidney Transplant Recipients","status":"RECRUITING","sponsor":"University of California, Davis","startDate":"2021-09-24","conditions":"COVID-19, Immunosuppression, Vaccine Response Impaired","enrollment":50},{"nctId":"NCT04884490","phase":"PHASE2, PHASE3","title":"The Role of High Dose Co-trimoxazole in Severe Covid-19 Patients","status":"COMPLETED","sponsor":"Bangabandhu Sheikh Mujib Medical University, Dhaka, Bangladesh","startDate":"2021-05-15","conditions":"COVID-19 Pneumonia","enrollment":94},{"nctId":"NCT04536090","phase":"PHASE2","title":"Study of Isoquercetin (IQC-950AN) Plus Standard of Care Versus Standard of Care Only for the Treatment of COVID-19","status":"WITHDRAWN","sponsor":"Institut de Recherches Cliniques de Montreal","startDate":"2022-01","conditions":"COVID-19","enrollment":""},{"nctId":"NCT06883643","phase":"NA","title":"Adoption of Innovative Approaches to Ensure Continuity of Quality TB Services During COVID-19 Pandemic in Lusaka and Livingstone, Zambia. (Telemedicine in TB)","status":"COMPLETED","sponsor":"Centre for Infectious Disease Research in Zambia","startDate":"2022-02-04","conditions":"Focus of the Study is to Evaluate DSD Models for Both TB Treatment and TPT Usiing Key Performance Indicators","enrollment":3318},{"nctId":"NCT04871893","phase":"NA","title":"Safety and Efficacy Evaluation of CO2 Removal in Combination With Continuous Veno-Venous Hemodialysis/Hemodiafiltration Therapy","status":"COMPLETED","sponsor":"Fresenius Medical Care Deutschland GmbH","startDate":"2022-03-25","conditions":"Acute Lung Injury, Acute Kidney Injury, Hypercapnia","enrollment":28},{"nctId":"NCT04900961","phase":"NA","title":"CISCO-21 Prevent and Treat Long COVID-19.","status":"COMPLETED","sponsor":"NHS Greater Glasgow and Clyde","startDate":"2021-06-01","conditions":"Covid19","enrollment":233},{"nctId":"NCT04378244","phase":"PHASE1, PHASE2","title":"CORONA: A Study Using DeltaRex-G Gene Therapy for Symptomatic COVID-19","status":"WITHDRAWN","sponsor":"Aveni Foundation","startDate":"2022-12-12","conditions":"COVID-19, Cytokine Storm, Acute Respiratory Distress Syndrome","enrollment":""},{"nctId":"NCT04410328","phase":"PHASE3","title":"Aggrenox To Treat Acute Covid-19","status":"COMPLETED","sponsor":"Rutgers, The State University of New Jersey","startDate":"2020-10-21","conditions":"Covid19","enrollment":98},{"nctId":"NCT04386070","phase":"PHASE3","title":"Preventing Pulmonary Complications in Surgical Patients at Risk of COVID-19","status":"SUSPENDED","sponsor":"University of Birmingham","startDate":"2022-05-16","conditions":"Pulmonary Complications in Surgical Patients, COVID, Severe Acute Respiratory Syndrome","enrollment":6400},{"nctId":"NCT04790240","phase":"PHASE1, PHASE2","title":"Medical Herbs Inhibit Inflammation Directing T Cells to Kill the COVID-19 Virus (COVID)","status":"RECRUITING","sponsor":"All Natural Medicine Clinic, LLC","startDate":"2025-01-01","conditions":"Covid19 Virus Infection","enrollment":100},{"nctId":"NCT04573153","phase":"PHASE2, PHASE3","title":"Metabolic Cofactor Supplementation and Hydroxychloroquine Combination in Covid-19 Patients","status":"TERMINATED","sponsor":"ScandiBio Therapeutics AB","startDate":"2020-09-21","conditions":"COVID-19","enrollment":100},{"nctId":"NCT05269888","phase":"","title":"Covid-19 Vaccine Immune Response in Multiple Sclerosis","status":"ACTIVE_NOT_RECRUITING","sponsor":"University Hospitals of North Midlands NHS Trust","startDate":"2022-02-16","conditions":"Multiple Sclerosis","enrollment":240},{"nctId":"NCT06052436","phase":"PHASE1, PHASE2","title":"Cell Therapy With Treg Cells Obtained From Thymic Tissue (thyTreg) to Control the Immune Hyperactivation Associated With COVID-19 and/or Acute Respiratory Distress Syndrome (THYTECH2)","status":"RECRUITING","sponsor":"Hospital General Universitario Gregorio Marañon","startDate":"2023-06-27","conditions":"Systemic Inflammatory Response Syndrome","enrollment":24},{"nctId":"NCT04362085","phase":"PHASE3","title":"Coagulopathy of COVID-19: A Pragmatic Randomized Controlled Trial of Therapeutic Anticoagulation Versus Standard Care","status":"COMPLETED","sponsor":"Unity Health Toronto","startDate":"2020-05-11","conditions":"COVID-19","enrollment":465}],"_emaApprovals":[],"_faersSignals":[],"_approvalHistory":[],"publicationCount":3,"rwe":[],"genericFilers":[],"relatedDrugs":[],"labelChanges":[],"biosimilarFilings":[],"pricing":[],"formularyStatus":[],"manufacturing":[],"companionDiagnostics":[],"competitors":[],"timeline":[],"patents":[],"ownershipHistory":[],"trials":[],"biosimilars":[],"latestUpdates":[],"references":[],"tags":[],"ecosystem":[],"genericManufacturerList":[],"offLabel":[],"developmentCodes":[],"aliases":["Drugs accepted as cures for COVID-19"],"phase":"phase_2","status":"active","brandName":"COVID-19 Standard Treatment","genericName":"COVID-19 Standard Treatment","companyName":"Dermama Bioteknologi Laboratorium","companyId":"dermama-bioteknologi-laboratorium","modality":"Small molecule","firstApprovalDate":"","aiSummary":"This drug targets the SARS-CoV-2 virus to prevent COVID-19 infection. Used for Prevention of COVID-19 disease.","enrichmentLevel":3,"visitCount":1,"trialStats":{"total":0,"withResults":0},"verificationStatus":"verified","dataCompleteness":{"mechanism":true,"indications":true,"safety":true,"trials":true,"score":4}}